Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study
Authors
Keywords
-
Journal
Annals of Clinical and Translational Neurology
Volume 8, Issue 1, Pages 66-80
Publisher
Wiley
Online
2020-12-18
DOI
10.1002/acn3.51254
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolutionary redesign of the lysosomal enzyme arylsulfatase A increases efficacy of enzyme replacement therapy for metachromatic leukodystrophy
- (2019) Heidi Simonis et al. HUMAN MOLECULAR GENETICS
- Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers
- (2019) Magdalena Harrington et al. Orphanet Journal of Rare Diseases
- Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective
- (2019) Shanice Beerepoot et al. Orphanet Journal of Rare Diseases
- Bridging barriers: a comparative look at the blood–brain barrier across organisms
- (2018) Natasha M. O'Brown et al. GENES & DEVELOPMENT
- Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future
- (2017) David Whiteman et al. Drug Design Development and Therapy
- Efficacy of hematopoietic cell transplantation in metachromatic leukodystrophy: the Dutch experience
- (2016) D. F. van Rappard et al. BLOOD
- Emerging drugs for the treatment of mucopolysaccharidoses
- (2016) Roberto Giugliani et al. EXPERT OPINION ON EMERGING DRUGS
- Therapies of lysosomal storage disorders targeting the brain
- (2016) Ingeborg Krägeloh-Mann et al. LANCET
- Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
- (2016) Maria Sessa et al. LANCET
- Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients
- (2016) Samuel Groeschel et al. JAMA Neurology
- Metachromatic leukodystrophy: Disease spectrum and approaches for treatment
- (2015) Diane F. van Rappard et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Enzymes Approved for Human Therapy: Indications, Mechanisms and Adverse Effects
- (2015) Brian A. Baldo BIODRUGS
- Concurrent validity of the differential ability scales, second edition with the Mullen Scales of Early Learning in young children with and without neurodevelopmental disorders
- (2015) Cristan Farmer et al. CHILD NEUROPSYCHOLOGY
- Mutation Update ofARSAandPSAPGenes Causing Metachromatic Leukodystrophy
- (2015) Martina Cesani et al. HUMAN MUTATION
- Language and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort
- (2014) Christiane Kehrer et al. Orphanet Journal of Rare Diseases
- Intrathecal delivery of protein therapeutics to the brain: A critical reassessment
- (2014) Pericles Calias et al. PHARMACOLOGY & THERAPEUTICS
- Pediatric Lumbar Puncture and Cerebrospinal Fluid Analysis
- (2013) William Bonadio JOURNAL OF EMERGENCY MEDICINE
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
- (2013) A. Biffi et al. SCIENCE
- Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age
- (2012) F. Matthes et al. HUMAN MOLECULAR GENETICS
- Cerebral gray and white matter changes and clinical course in metachromatic leukodystrophy
- (2012) S. Groeschel et al. NEUROLOGY
- The natural course of gross motor deterioration in metachromatic leukodystrophy
- (2011) CHRISTIANE KEHRER et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy
- (2011) S. Stroobants et al. HUMAN MOLECULAR GENETICS
- Motor and Sensory Conduction in Infancy and Childhood: Reappraisal
- (2010) Anna Lise Wagner et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- THE GROSS MOTOR FUNCTION MEASURE: A MEANS TO EVALUATE THE EFFECTS OF PHYSICAL THERAPY
- (2010) Dianne J. Russell et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Development and reliability of a system to classify gross motor function in children with cerebral palsy
- (2010) Robert Palisano et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy
- (2010) C. i Dali et al. NEUROLOGY
- Metachromatic Leukodystrophy – An Update
- (2010) V. Gieselmann et al. NEUROPEDIATRICS
- Metachromatic Leukodystrophy: A Scoring System for Brain MR Imaging Observations
- (2009) F. Eichler et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Development of the Gross Motor Function Classification System for cerebral palsy
- (2009) Peter L Rosenbaum et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Enzyme Replacement Improves Ataxic Gait and Central Nervous System Histopathology in a Mouse Model of Metachromatic Leukodystrophy
- (2009) Ulrich Matzner et al. MOLECULAR THERAPY
- Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options
- (2008) Volkmar Gieselmann ACTA PAEDIATRICA
- Lysosomal Storage Diseases and the Blood-Brain Barrier
- (2008) David Begley et al. CURRENT PHARMACEUTICAL DESIGN
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now